Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Applied Immunohistochemistry & Molecular Morphology : AIMM|March 2, 2017
Distribution of RANK and RANK Ligand in Normal Human Tissues as Determined by an Optimized Immunohistochemical MethodClive R Taylor, Daniel Branstetter, Edward Manna, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 12, 2014
Intravital imaging reveals distinct responses of depleting dynamic tumor-associated macrophage and dendritic cell subpopulationsMarja Lohela, Amy-Jo Casbon, Aleksandra Olow, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 21, 2007
Receptor activator of NF-kappa B ligand inhibition suppresses bone resorption and hypercalcemia but does not affect host immune responses to influenza infectionRobert E Miller, Daniel Branstetter, Allison Armstrong, et al.
Journal of Bone Oncology|August 25, 2016
RANK and RANK ligand expression in primary human osteosarcomaDaniel Branstetter, Kathy Rohrbach, Li-Ya Huang, et al.
Breast Cancer Research : BCR|April 8, 2015
RANK-ligand (RANKL) expression in young breast cancer patients and during pregnancyHatem A Azim, Fedro A Peccatori, Sylvain Brohée, et al.
Breast Cancer Research : BCR|August 14, 2013
Progestin effects on cell proliferation pathways in the postmenopausal mammary glandCharles E Wood, Daniel Branstetter, Allison P Jacob, et al.
Breast Cancer Research and Treatment|July 11, 2014
RANKL expression in normal and malignant breast tissue responds to progesterone and is up-regulated during the luteal phaseHong Hu, Jun Wang, Akash Gupta, et al.
Breast Cancer Research and Treatment|April 17, 2014
RANK expression as a prognostic and predictive marker in breast cancerBerit Maria Pfitzner, Daniel Branstetter, Sibylle Loibl, et al.
Pageof 2